Cogent Biosciences
COGT
COGT
44 hedge funds and large institutions have $212M invested in Cogent Biosciences in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+16
Holders Change %
+57.14%
% of All Funds
1.01%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
28
Increased
5
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NLVP
New Leaf Venture Partners
New York
|
$25.8M |
| 2 |
BlackRock
New York
|
$6.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$7.6M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
$1.49M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
$771K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Citadel Advisors
Miami,
Florida
| – | -$416K | -9,350 | Closed |
|
|
DIM
52
DC Investments Management
Mclean,
Virginia
| – | -$395K | -8,881 | Closed |
|
|
AC
53
Athanor Capital
New York
| – | -$248K | -5,575 | Closed |
|
|
DCM
54
DAFNA Capital Management
Los Angeles,
California
| – | -$88K | -1,975 | Closed |
|